| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 962,520 | 1,248 |
| Effect of foreign exchange rate changes, net | 36,862 | 26,957 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 1,471,795 | 147,339 |
| Cash and cash equivalents at beginning of period | 2,638,747 | - |
| Cash and cash equivalents at end of period | 4,110,542 | - |
BeOne Medicines Ltd. (BEIGF)
BeOne Medicines Ltd. (BEIGF)